PD Dr. Markus Eckstein

Institute of Pathology

Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial (2026) Reck M, Waller C, Sadjadian P, Kambartel K, Grohé C, Sendler A, Reinmuth N, et al. Journal article NECTIN4 Amplification Is a Frequent Event in Central Nervous System Metastases of Urothelial Carcinoma (2026) Weiten R, Rieger C, Heidenreich J, Tolkach Y, Stehle T, Schmid F, Schmidt T, et al. Journal article Spatial transcriptomics expression prediction from histopathology based on cross-modal mask reconstruction and contrastive learning (2026) Liu J, Eckstein M, Wang Z, Feuerhake F, Merhof D Journal article Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications Therapieinduziertes neuroendokrines Prostatakarzinom (tNEPC) – Eine Herausforderung in der Uro-Onkologie: Diagnostik, klinische Relevanz und therapeutische Perspektiven (2026) von Amsberg G, Hartmann A, Eckstein M, Heidegger I Journal article, Review article From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma Von ungezielt zu Präzisionsonkologie: Prädiktive Biomarker und Target-Therapien beim fortgeschrittenen Urothelkarzinom (2026) Niegisch G, Zschäbitz S, Eckstein M, Klümper N Journal article, Review article Nectin-4 in bladder cancer: biology and predictive biomarker potential. (2026) Roessler N, Miszczyk M, Berger W, Englinger B, Eckstein M, Shariat SF Journal article, Review article The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review (2026) Fiegl A, Mink J, Junker K, Hartmann A, Eckstein M Journal article, Review article Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025) Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, et al. Journal article Loss of p190A RhoGAP induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamics (2025) Kang Q, Kong X, Najjar G, Azoitei A, Eckstein M, John A, Zengerling F, et al. Journal article TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy (2025) Kessler C, von Brandenstein M, Klümper N, Krausewitz P, Storz E, Rieger C, Sperber L, et al. Journal article